Vasorum USA, Inc. announced FDA approval of the Celt ACD Plus system, which is designed for rapid arterial puncture closure ...

Since the mid-1990s, however, vascular closure devices (VCDs) have been introduced into clinical practice with the aim of improving efficacy and safety. Different types of VCDs have been developed ...

CHARLOTTE, N.C., March 27, 2025 /PRNewswire/ -- Vasorum USA, Inc, a privately held, commercial-stage medical device company dedicated to redefining vascular closure, today announced U.S. Food and ...

Discover why suture-based closure may be safer for TAVI patients. Learn more about this large registry analysis.

Haemonetics updated its hospital revenue guidance to 24% to 26% reported growth and 12% to 14% organic growth, driven by strong adoption of hemostasis cartridges and vascular closure devices.

and Efficacy of a Novel External Compression Vascular Closure Device: The LockeT Study (interim study data) Abstract at the American College of Cardiology meeting titled Feasibility, Safety ...

The U.S. small bore arterial vascular closure device market, valued at $600 million in 2023, is projected to reach $1 billion by 2032. This growth is driven by the increasing prevalence of ...